Non-Alcoholic Steatohepatitis Supplement Market Report Scope & Overview:

The Non-Alcoholic Steatohepatitis Supplement Market size was USD 762.4 million in 2022 and is expected to Reach USD 1019.5 million by 2030 and grow at a CAGR of 3.7 % over the forecast period of 2023-2030. 

Non-alcoholic steatohepatitis (NASH) is a liver disease that causes inflammation and scarring as a result of fat accumulation that affects millions of individuals worldwide. NASH is also linked to an increased risk of cardiovascular disease and other metabolic illnesses, with sedentary lifestyles being the root reason.

The European Liver Patients Association (ELPA) brought together the EU NASH Summit on June 2023, in the European Parliament to increase awareness and develop interaction among stakeholders on this public health concern. People with NASH are susceptible to liver fibrosis, which can progress to cirrhosis, placing them at high risk of death from liver failure or malignancy. As a result, the region's need for non-alcoholic steatohepatitis supplements has soared. As a result of the aforementioned factors, the Asia-Pacific region accounted for the biggest market share throughout the forecast period.

MARKET DYNAMICS

KEY DRIVERS

• Increasing initiatives to promote awareness of NASH

The market for NASH supplements is still in its early stages, and many consumers may be not aware of the possible benefits of taking supplements. NASH and its symptoms are made more widely known through public education programs. They also offer information on available treatments, such as NASH supplements. Overall, growing awareness about the potential advantages of NASH supplements among patients and healthcare professionals is encouraging their usage in the treatment of NASH and related metabolic disorders. To ensure safe and efficient use, supplements should be used in tandem with other lifestyle changes under the supervision of a healthcare practitioner.

RESTRAIN

• Side-effects of NASH Supplements

Like any other medicine, NASH supplements may cause undesired side effects or interfere with other medications. High doses of vitamin E supplements, for example, may increase the risk of bleeding in individuals on blood thinners, and omega-3 fatty acid supplements might interact with certain cholesterol-reducing drugs. Furthermore, supplement safety and efficacy may vary depending on every patient's medical condition and other medications they might be consuming.  

• Lack of awareness of potential benefits of NASH supplements

OPPORTUNITY

• Research & Development in NASH Supplements

NASH is a severe type of fatty liver disease that can cause serious liver damage and have a significant influence on overall health. There is an increase in investment in R&D activities for improved treatment of NASH illnesses. Future research is needed to further investigate the causes of NASH so that medicines can help reverse the underlying mechanisms. There are no effective treatments for NASH at the moment, however, a new study discovered that folate and vitamin B12 could help reduce scarring and inflammation in human patients and animal models.

CHALLENGES

• The high cost of some NASH supplements

The high cost of NASH supplements is attributed to a variety of variables, including manufacturing costs and the high expense of developing and testing novel supplements. This makes NASH supplements costlier, especially when taken for an extended period of time. This can make them expensive for certain consumers, particularly those who are already burdened financially by other medical bills.

IMPACT OF RUSSIA-UKRAINE WAR

Russia Ukraine has destroyed the healthcare system in Ukraine. More than 6.1 million people have been displaced by the war, many of whom are now living in cramped, unhygienic conditions, increasing their risk of getting diseases like hepatitis A and E, which can cause liver damage. Healthcare services have been affected by the war as well, making it challenging for those with liver illnesses to access the care they require. Also, the disruption in the supply chain of any medication like NASH supplement may delay the treatment of diseases. Many hospitals were damaged in Ukraine and people migrated to Europe fueling a humanitarian crisis with lasting effects. This might worsen the severity of liver disease consequences such as cirrhosis and hepatocellular cancer. There is a stagnant demand for NASH supplements but disruption in supply and war may impede market growth.

IMPACT OF ONGOING RECESSION

Despite the recession, people require critical disease medical treatment but to save money, people forgo medical attention for non-life-threatening diseases and minor disorders. Patients are concerned because they don’t have enough money to pay their medical expenditures. The number of patients who failed to show up for their appointments increased dramatically during the recession. The number of persons experiencing severe stress symptoms has increased, it is expected to rise in the aftermath of a recession as people cope with stress and financial difficulty. As consumers cut down on health supplements their consumption of NASH supplements decreases.

MARKET SEGMENTATION

By Type

• Probiotics

• Pre-biotic

• Synbiotics

• Postbiotic

By Supplement Form

• Tablet

• Capsule

• Powder

• Others

By Nutrition

• Milk thistle

• Turmeric

• Vitamin E

• Omega-3-fatty acids

REGIONAL ANALYSIS

Asia-Pacific region will hold the biggest market share in 2022. The rising prevalence of obesity, rising NASH incidence, and increased product launches will fuel the region's growth during the projection period. For example, in many Asian countries, including South Korea, the obesity epidemic is on the increase, as is NAFLD. People with obesity or diabetes mellitus possess a higher prevalence of NAFLD than the overall population.

North America is growing as a market for NASH supplements because people are more aware of the possible health advantages of supplements and are turning to them to maintain their health and avoid disease. NAFLD is the most frequent chronic liver ailment in the United States, according to the American Liver Foundation 2022. It is estimated that approximately 25% of adults in the United States have NAFLD. NASH affects approximately 20% of persons with NAFLD (5% of adults in the United States).

Europe is expected to expand as a market for NASH supplements. NASH affects 10 million people or 18% of the Europe population, and its prevalence is anticipated to rise by more than 40% by 2030. Consumers become more aware of the possible health advantages of supplements, and many are turning to supplements to manage their health and avoid disease. NASH is becoming more common in Europe, and its incidence is projected to rise further in the future years.

REGIONAL COVERAGE

North America

• US

• Canada

• Mexico

Europe

• Eastern Europe

  • Poland

  • Romania

  • Hungary

  • Turkey

  • Rest of Eastern Europe

• Western Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Netherlands

  • Switzerland

  • Austria

  • Rest of Western Europe

Asia Pacific

• China

• India

• Japan

• South Korea

• Vietnam

• Singapore

• Australia

• Rest of Asia Pacific

Middle East & Africa

• Middle East

  • UAE

  • Egypt

  • Saudi Arabia

  • Qatar

  • Rest of Middle East

• Africa

  • Nigeria

  • South Africa

  • Rest of Africa

Latin America

• Brazil

• Argentina

• Colombia

• Rest of Latin America

KEY PLAYERS

Some key players are Nature's Bounty (Nestlé), NOW Foods, Herbalife International of America, Inc., DANONE S.A., ADM, Irwin Naturals, Oregon's Wild Harvest, Jarrow Formulas, Inc, Gaia Herbs and Nutra-Life Australia, Intercept Pharmaceuticals, Inc., Evogen Nutrition, and other key players.

Herbalife International of America Inc-Company Financial Analysis

RECENT DEVELOPMENTS

In 2023, Intercept Pharmaceuticals, Inc. announced a restructuring to improve the Company's focus on rare and critical liver disorders while dramatically reducing operating expenses, including the discontinuation of all nonalcoholic steatohepatitis (NASH)-related funding.

In 2023, Nestlé introduced Nature's Bounty in the Philippines, a line of five non-GMO (genetically modified organism) supplements with no artificial flavors, colors, or sweeteners.

In 2023, Evogen Nutrition, a pioneer in sports nutrition and supplements, introduced a new liver support supplement designed to improve liver health and performance.